Two groups are fighting for an edge in one of the most lucrative drug classes in the pharmaceutical industry’s history.

Tokyo's benchmark Nikkei 225 index has fallen more than 4% and other shares in Asia also sank after a retreat on Wall Street ...

The bidding war over biotechnology company Metsera (MTSR) has intensified, drawing fierce competition from pharmaceutical ...

Eli Lilly and Novo Nordisk are expected to announce price reductions for their weight-loss drugs as part of the TrumpRx ...

Investing.com -- Eli Lilly and Novo Nordisk are planning to announce new drug pricing deals with the White House that include their weight loss medicines, according to a Tuesday report from Endpoints ...

Hims & Hers Health, Inc. (($HIMS)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call for Hims & ...